Biocatalytic production of novel glycolipids with cellodextrin phosphorylase
► Cellodextrin phosphorylase from Clostridium stercorarium is able to synthesize new glycolipids. ► Glucolipid and sophorolipid acceptors are extended with one or two glucosyl moieties. ► Product precipitation drives the reactions to near completion and facilitates purification. ► The glycosyl donor...
Saved in:
Published in | Bioresource technology Vol. 115; pp. 84 - 87 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.07.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ► Cellodextrin phosphorylase from Clostridium stercorarium is able to synthesize new glycolipids. ► Glucolipid and sophorolipid acceptors are extended with one or two glucosyl moieties. ► Product precipitation drives the reactions to near completion and facilitates purification. ► The glycosyl donor α-galactose 1-phosphate allows the synthesis of lactolipid in highly pure form.
Glycolipids have gained increasing attention as natural surfactants with a beneficial environmental profile. They are typically produced by fermentation, which only gives access to a limited number of structures. Here we describe the biocatalytic production of novel glycolipids with the cellodextrin phosphorylase from Clostridium stercorarium. This enzyme was found to display a broad donor and acceptor specificity, allowing the synthesis of five different products. Indeed, using either α-glucose 1-phosphate or α-galactose 1-phosphate as glycosyl donor, sophorolipid as well as glucolipid could be efficiently glycosylated. The transfer of a glucosyl moiety afforded a mixture of products that precipitated from the solution, resulting in near quantitative yields. The transfer of a galactosyl moiety, in contrast, generated a single product that remained in solution at thermodynamic equilibrium. These glycolipids not only serve as a new class of biosurfactants, but could also have applications in the pharmaceutical and nanomaterials industries. |
---|---|
Bibliography: | http://dx.doi.org/10.1016/j.biortech.2011.09.085 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0960-8524 1873-2976 |
DOI: | 10.1016/j.biortech.2011.09.085 |